Back
MACOM Technology Solutions Holdings 10K Form
Buy
89
MTSI
MACOM Technology Solutions Holdings
Last Price:
131.34
Seasonality Move:
11.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MTSI News And Ratings
See the #1 stock for the next 7 days that we like better than MTSI
MTSI Financial Statistics
Sales & Book Value
| Annual Sales: | $729.58M |
|---|---|
| Cash Flow: | $57.14M |
| Price / Cash Flow: | 68.92 |
| Annual Sales: | $15.60 |
| Price / Book: | 8.44 |
Profitability
| EPS (TTM): | 1.03000 |
|---|---|
| Net Income (TTM): | $76.86M |
| Gross Margin: | $393.77M |
| Return on Equity: | 7.36% |
| Return on Assets: | 4.61% |
MACOM Technology Solutions Holdings Earnings Forecast
Key MACOM Technology Solutions Holdings Financial Ratios
- The Gross Profit Margin over the past 16 years for MTSI is 53.97%.
- The Selling, General & Administrative Expenses for MTSI have been equal to 18.91% of Gross Profit Margin.
- The Research & Development expenses have been 24.97% of Revenue.
- The Interest Expense is 6.68% of Operating Income.
- The Net Earning history of MTSI is 10.53% of Total Revenues.
- Per Share Earnings over the last 16 years have been positive in 7 years.
MACOM Technology Solutions Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Semiconductors & Semiconductor Equipment |
| Sector: | Information Technology |
| Current Symbol: | MTSI |
| CUSIP: | 55405Y |
| Website: | macom.com |
Debt
| Debt-to-Equity Ratio: | 0.4 |
|---|---|
| Current Ratio: | 8.35 |
| Quick Ratio: | 6.36 |
Price-to-Earnings
| Trailing P/E Ratio: | 126.28 |
|---|---|
| Forward P/E Ratio: | 32.87 |
MTSI Technical Analysis vs Fundamental Analysis
Buy
89
MACOM Technology Solutions Holdings (MTSI)
is a Buy
Is MACOM Technology Solutions Holdings a Buy or a Sell?
-
MACOM Technology Solutions Holdings stock is rated a Buy
The current MACOM Technology Solutions Holdings [MTSI] share price is $131.33. The Score for MTSI is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.